Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for children
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on children or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on children and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
Acute Treatment of Migraine in Children and Adolescents 1 Practice guideline update: Acute treatment of migraine in children and adolescents 1 Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the 2 American Academy of Neurology and the American Headache Society 3 4 Maryam Oskoui, MD, MSc, 1 Tamara Pringsheim, MD, 2 Yolanda Holler-Managan, MD, 3 Sonja 5 Potrebic, MD, PhD, 4 Lori Billinghurst MD, MSc, 5 David Gloss, MD, 6 Andrew D. Hershey, MD, 6 PhD, 7 (...) School of Medicine, University of Calgary, Canada 16 4. Neurology Department, Southern California Permanente Medical Group, Kaiser, Los 17 Angeles 18 5. Division of Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA 19 6. Department of Neurology, Charleston Area Medical Center, Charleston, WV 20 7. Division of Neurology, Cincinnati Children’s Hospital Medical Center, OH 21 2 8. Department of Neuroscience and Spine, St. Anthony Hospital—Centura Health, 1 Lakewood, CO 2 3 9. University
Global climate change and health in Canadian children Climate change is a reality. Numerous expert authorities warn of the critical need to undertake and adapt environmental efforts to protect human health. Climate change is accelerating, and countries in high latitudes, such as Canada, are experiencing climate change more directly and, for some end points, more dramatically than mid- and low-latitude countries. Children are vulnerable to climate change health effects, and physicians (...) and other health care providers need to be ready to identify, manage, and prevent climate change-related health hazards. This practice point highlights specific, climate change-related threats to the health of children and youth, and provides resources for health care providers. Climate challenges and their health impacts on children are described, based on key Canadian reports and scientifically referenced information. Enhanced awareness of the immediate and longer term health effects of climate change
Improving paediatric medications: A prescription for Canadian children and youth In Canada, policies governing medication approval and reimbursement are based largely on adult standards, and the evaluation of new medicines employs adult return-on-investment benchmarks. Research funding for adult diseases is often prioritized over that for childhood illnesses. Canada lags other countries in implementing regulatory and research-related reforms that take the unique characteristics of children (...) and youth into account. To ensure that children and youth have timely access to safe, effective medications, including child-friendly formulations, the federal government must pursue paediatric-focused reforms that consider their unique health needs throughout the drug life cycle. Regulatory reform must be guided by principles of fairness and equity, always recognizing that children deserve the same standards of drug safety, efficacy, availability, and access as adults. Paediatric experts must drive
Lead toxicity with a new focus: Addressing low-level lead exposure in Canadian children Although acute and subacute lead toxicity requiring active treatment is rare in Canada, paediatricians need to be aware of new evidence linking lower lead levels to neurodevelopmental deficits. Health Canada has identified potential exposures occurring prenatally, in infancy and during early childhood from food and water, household dust, soil and mouthing products that contain lead. Children
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years. Attention deficit hyperactivity disorder (ADHD) in children is associated with hyperactivity and impulsivity, attention problems, and difficulties with social interactions. Pharmacological treatment may alleviate the symptoms of ADHD but this rarely solves difficulties with social interactions. Children with ADHD may benefit from interventions designed to improve their social skills. We (...) examined the benefits and harms of social skills training on social skills, emotional competencies, general behaviour, ADHD symptoms, performance in school of children with ADHD, and adverse events.To assess the beneficial and harmful effects of social skills training in children and adolescents with ADHD.In July 2018, we searched CENTRAL, MEDLINE, Embase, PsycINFO, 4 other databases and two trials registers.We also searched online conference abstracts, and contacted experts in the field
Probiotics for preventing acute otitis media in children. Acute otitis media (AOM), or acute middle ear infection, is one of the most frequently occurring childhood diseases, and the most common reason given for prescribing antibiotics in this age group. Guidelines often recommend antibiotics as first-line treatment for severe AOM. However, antibiotics also lead to antibiotic resistance, so preventing episodes of AOM is an urgent priority.To assess the effects of probiotics to prevent (...) the occurrence and reduce the severity of acute otitis media in children.We searched CENTRAL, PubMed, Embase, and three other databases (October 2018), two trial registers (October 2018), and conducted a backwards and forwards citation analysis (August 2018). We did not apply any language, publication date, or publication status restrictions.Randomised controlled trials (RCTs) of children (aged up to 18 years), comparing probiotics with placebo, usual care, or no probiotic.Two review authors independently
Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015 To examine the incidence, mortality, and health care use related to neonatal herpes simplex virus (HSV) infection.A retrospective longitudinal cohort study using a multistate Medicaid claims database. We identified neonates hospitalized with HSV infection from 2009 to 2015 by using discharge diagnosis codes and managed them for 6 months after discharge. Incidence rates were corrected for the imperfect
Growth Monitoring for Children with Chronic Kidney Disease S Trace, E Cameron, C Inward, CP Burren, Feb 2019 Review date Feb 2022 Page 1 of 5 Bristol Royal Hospital for Children Growth Monitoring Guideline for Children with CKD Contents Page 1-2 Scope, Background, Rationale and Evidence base for guideline Page 2 Definition of Stages of Chronic Kidney Disease (CKD) Page 3 Notes on Growth Monitoring and Referral Page 4 Growth Monitoring Timetable Page 5 References The guideline scope extends (...) to both specialist renal units and shared care centres, including those where children are seen by non-specialist paediatricians. This guideline provides guidance on the monitoring of growth in children and young people with CKD. Where this monitoring indicates growth concerns, clinicians should manage and refer cases according to their local or regional paediatric endocrine referral pathways. Background: Growth retardation is well documented in children with CKD 1,2,3,4 , even in children with mild
Can S100B Serum Biomarker Testing Reduce Head Computed Tomography Scanning in Children With Mild Traumatic Brain Injury? Can S100B Serum Biomarker Testing Reduce Head Computed Tomography Scanning in Children With Mild Traumatic Brain Injury? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 73, Issue 5, Pages 456–458 Can S100B Serum Biomarker Testing Reduce Head Computed Tomography Scanning (...) in Children With Mild Traumatic Brain Injury? x Steven K. Roumpf , MD (EBEM Commentator) IU Health Academic Health Center, Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN x Julie L. Welch , MD (EBEM Commentator) Indiana Clinical and Translational Science Institute, Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN DOI: | Publication History Published online: November 20, 2018 Expand all Collapse all Article Outline Take-Home
Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings Miller BS, et al. J Investig Med 2019;0:1–10. doi:10.1136/jim-2019-000999 1 Review Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings Bradley S Miller, 1 Sandra P Spencer, 2 Mitchell E Geffner, 3 Evgenia Gourgari, 4 Amit Lahoti, 5 Manmohan K Kamboj, 2 Takara L Stanley, 6 Naveen K Uli, 7 Brandy (...) A Wicklow, 8 Kyriakie Sarafoglou 1 To cite: Miller BS, Spencer SP , Geffner ME, et al. J Investig Med Epub ahead of print: [please include Day Month Year]. doi:10.1136/jim-2019- 000999 For numbered affiliations see end of article. Correspondence to Dr Bradley S Miller, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, 2450 Riverside Ave, Minneapolis, MN 55454, USA; mille685@ umn. edu The work has been presented at Pediatric Academic Society Meeting 2018, ’Year In Review
Digital media: Promoting healthy screen use in school-aged children and adolescents Digital media are integrated into the everyday lives of children and adolescents, with potential benefits and risks for learning, mental and physical health, and for social life. This statement examines the cognitive, psychosocial, and physical effects of digital media on school-aged children and adolescents, with a focus on family routines, context, and activities. Evidence-based guidance for clinicians (...) and families involves four principles: healthy management , meaningful screen use, positive modelling , and balanced, informed monitoring of screen time and behaviours. Keywords: Adolescents; Children; Development; Digital media; Family; Health; Screen use
Are Antibiotics Effective in the Treatment of Children With Prolonged Wet Cough? Are Antibiotics Effective in the Treatment of Children With Prolonged Wet Cough? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 73, Issue 5, Pages 453–455 Are Antibiotics Effective in the Treatment of Children With Prolonged Wet Cough? x Brit Long , MD (EBEM Commentator) , x Michael D. April , MD, DPhil (EBEM (...) Commentator) Department of Emergency Medicine, San Antonio Uniformed Services Health Education Consortium, Fort Sam Houston, TX DOI: | Publication History Published online: November 13, 2018 Expand all Collapse all Article Outline Take-Home Message Antibiotics may improve clinical cure and reduce progression of illness in children with prolonged wet cough. Methods Data Sources Authors identified trials from the Cochrane Airways Trials Register, CENTRAL, MEDLINE OvidSP, and EMBASE OvidSP through September
Health Care Support Workers Administering Inactivated Influenza, Shingles and Pneumococcal Vaccines for Adults and Live Attenuated Influenza Vaccine (LAIV) for Children CLINICAL PROFESSIONAL RESOURCE Health Care Support Workers Administering Inactivated Influenza, Shingles and Pneumococcal Vaccines for Adults and Live Attenuated Influenza Vaccine (LAIV) for Children RCN guidance Version 3 revised 2019 This RCN document applies in England and Wales in line with the National Minimum Standards (...) (PHE 2015). These standards are not endorsed in Northern Ireland or Scotland although it is acknowledged that the principles may still provide useful guidance. This version replaces all previous RCN guidance to support HCSW and vaccination. HEALTH CARE SUPPORT WORKERS ADMINISTERING VACCINES FOR ADULTS AND CHILDREN 2 Acknowledgements The authors would like to thank those individuals, groups and organisations that have contributed to this Royal College of Nursing publication, particularly the support
Fluticasone/formoterol (Flutiform) - the regular treatment of asthma in children aged 5 to 12 years 1 Published 10 June 2019 1 Product update SMC2178 fluticasone propionate/formoterol fumarate metered dose inhaler 50 microgram/5 microgram (flutiform®) Napp Pharmaceuticals Ltd 10 May 2019 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland. The advice (...) is summarised as follows: ADVICE: following an abbreviated submission fluticasone propionate/formoterol fumarate (flutiform®) is accepted for use within NHSScotland. Indication under review: the regular treatment of asthma in children aged 5 to 12 years where the use of a combination product (an inhaled corticosteroid and a long-acting ß 2 agonist) is appropriate: • For patients not adequately controlled with inhaled corticosteroids and 'as required' inhaled short-acting ß 2 agonist. Or • For patients